by admin | Dec 8, 2021 | Business, Funding, Healthcare, Research
Hemostatics is a spin-off company from Cima Universidad de Navarra. Hemostatics Pharmaceuticals is performing the preclinical and clinical development of the antifibrinolytic agent CM-352, a first-in-class drug that represents a pioneering therapeutic approach to...
by admin | Jun 30, 2020 | Funding
Novo Ventures, part of Novo Holdings, today announced that it has led the $55 million (£44 million) Series B financing in NodThera, a UK and US based clinical stage biotechnology company developing a new class of medicines to treat diseases driven by chronic...
by admin | Jun 30, 2020 | Funding
Solvias Completes Agreement with Strategic Healthcare Investors to Advance Expansion Global Pharmaceutical Laboratory Services Company Appoints Two Seasoned Industry Executives to Board of Directors – Solvias Completes Agreement with Strategic Healthcare...
